Back
Cardiol Therapeutics Vs. ESSA Pharma Industry Stock Comparison
Sell
50
CRDL
Cardiol Therapeutics
Last Price:
1.62
Seasonality Move:
35.88%
Sell
16
EPIX
ESSA Pharma
Last Price:
1.84
Seasonality Move:
36.87%
Sell
50
Cardiol Therapeutics (CRDL)
is a Sell
Is Cardiol Therapeutics a Buy, Sell or Hold?
- The current Cardiol Therapeutics [CRDL] share price is $1.62. The Score for CRDL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CRDL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
ESSA Pharma (EPIX)
is a Sell
Is ESSA Pharma a Buy, Sell or Hold?
- The current ESSA Pharma [EPIX] share price is $1.83. The Score for EPIX is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- EPIX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CRDL Stock Price Chart
What is Cardiol Therapeutics's stock price today?
-
The Cardiol Therapeutics share price today is $1.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRDL is experiencing slight buying pressure.
EPIX Stock Price Chart
What is ESSA Pharma's stock price today?
-
The ESSA Pharma share price today is $1.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRDL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 34.48 | Sell |
Chaikin Money Flow: | 112900 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.72 - 1.96) | Sell |
Bollinger Bands (100): | (1.83 - 2.17) | Sell |
EPIX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.9 | Sell |
Relative Strength Index (14 RSI): | 26.56 | Sell |
Chaikin Money Flow: | 216428 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.26 - 4.96) | Sell |
Bollinger Bands (100): | (3.45 - 6.51) | Sell |
CRDL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.72 | Sell |
20-day SMA: | 1.83 | Sell |
50-day SMA: | 1.94 | Sell |
200-day SMA: | 1.96 | Sell |
8-day EMA: | 1.7 | Sell |
20-day EMA: | 1.8 | Sell |
50-day EMA: | 1.9 | Sell |
200-day EMA: | 1.84 | Sell |
EPIX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.75 | Buy |
20-day SMA: | 2.45 | Sell |
50-day SMA: | 4.63 | Sell |
200-day SMA: | 6.1 | Sell |
8-day EMA: | 1.83 | Sell |
20-day EMA: | 2.55 | Sell |
50-day EMA: | 3.88 | Sell |
200-day EMA: | 5.28 | Sell |
Cardiol Therapeutics Earnings Growth & CRDL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.67 per share, and an increase next year of $0.02 per share.
ESSA Pharma Earnings Growth & EPIX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.22 per share.
Cardiol Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ESSA Pharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |